ALEMBIC PHARMA LTD (APLLTD) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities.

APLLTDUpdated 1 Sept 2026, 2:21

Alembic Pharma Ltd

Market Cap

₹16,400Cr.

Current Price

₹835

High / Low

₹998/635

Stock P/E

20.8

ROE12.9%
ROCE12.3%
Book Value₹286
Face Value₹2.00
Dividend Yield1.44%

About

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities.

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days614557775469307285839088
Inventory Days195240237274325375376339280274403370
Days Payable162225177246173137148139131126148119
Cash Conversion Cycle9560117105207307258272234232345339
Working Capital Days4257829444588083851029489
ROCE %41%72%32%23%24%27%25%12%7%14%11%12%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 2:21


Designed & Shipped by Harshit Bansal